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Molecular Conformation, Receptor Binding,
and Hormone Action of Natural and
Synthetic Estrogens and Antiestrogens
by W. L. Duax,* J. F. Griffin,* C. M. Weeks,* and K. S.
Koracht
The X-ray crystallographic structural determinations of synthetic estrogens and antiestrogens provide
reliable information on the global minimum energy conformation of these molecules or a local minimum
energy conformation that is within 1 or 2 kcal/mole of the global minimum. In favorable cases, state-of-
the-art molecular mechanics calculations provide quantitative agreement with X-ray results and infor-
mationontherelativeenergyofotherlocalminimumenergyconformations notobservedcrystallographically.
Because the conformation of diethylstilbestrol (DES) observed in solvated crystals has an overall con-
formation and dipole moment more similar to estradiol it is the form more likely to bind to the receptor
and produce hormone activity. Either phenol ring of DES can successfully mimic the estradiol A-ring in
binding to the receptor. Indenestrol A (INDA) and indenestrol B (INDB) have nearly identical fully
extended planar conformations. Either the a or y rings of these compounds may mimic the A ring of
estradiol and compete forthe estrogen receptor. Although there are eight distinct ways in which molecules
of a racemic mixture of INDA or INDB can bind to the receptor, not all of them may be able to elicit a
hormonal response. This may account for the reduced biological activity of the compounds despite their
successful competition for receptor binding.
The minimum energy conformations ofZ-pseudodiethylstilbestrol (ZPD) and E-pseudodiethylstilbestrol
(EPD) are bent in a fashion similar to that of indanestrol (INDC). These molecules have good binding
affinity suggestingthat the receptor does not require a flat molecule. Therefore these conformations would
appear to be compatible with receptorbinding, but only the Z isomer has an energetically allowed extended
conformation that accounts for its observed biological activity relative to DES.
Introduction
Steroid hormones are vital to numerous physiological
processes including cell growth, sexual development,
maintenance ofsalt balance, and sugar metabolism. Many
ofthese activities are known to be contingent upon the
bindingofsteroids to specific cytosolic protein receptors
and the subsequent interaction of the steroid receptor
complex with chromatin. Abnormalities in steroid hor-
mone synthesis, metabolism and receptor interaction
contribute to a variety of diseases. Functional analogs
of steroids have been synthesized for therapeutic use
in restoring or controlling endogenous hormone levels.
Synthetic steroids are used extensively in fertility con-
trol, and antihormones that interfere with the synthe-
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sis, metabolism, and receptor binding of steroids are
useful in some forms ofchemotherapy. In addition, many
other chemicals, drugs, and naturally occurring com-
pounds have been shown to compete for the active sites
of steroid-metabolizing enzymes or the binding site of
steroid hormone receptors.
Because of the key role that steroids play in human
health and disease therapy, a full understanding ofthe
molecular details ofsteroid hormone action is essential.
A careful examination of the molecular structures and
three-dimensional shapes of the hormones, antihor-
mones, chemicals, and drugs that compete fora common
binding site on a specific receptor can provide infor-
mation on binding and the structural requirements for
the structural features that influence the extent and
nature of the hormonal response.
X-ray crystallographic determinations provide a highly
accurate picture ofmoleculargeometryin aspecific solid
state environment. Studying the same compound in dif-
ferent crystal forms provides additional information onDUAX ET AL.
the molecular flexibility of a compound (1,2). For most
uncharged organic molecules such as steroids, a struc-
ture observed in the solid state is at or very near a local
minimum energy conformation. If the energy of the
global minimum is 2 to 3 kcal/mole lower than that of
anymetastable state, it is highly probable that a crystal
incorporating the minimum energy conformation will be
formed preferentially. Iftwo or more conformations of
a flexible molecule are ofnearly equal energy they will
often form crystals incorporating both conformers either
as crystallographically independent molecules with dis-
similar environments (3) or as partial occupancy dis-
ordered molecules ina single site (4). Because the active
forms of drugs and hormones may not necessarily be
low energy forms it is important to have reliable infor-
mation onthe conformation andrelative energies ofmol-
ecules that may not be readily crystallizable. Such
information can be derived from solution and gas phase
measurements and theoretical calculations. X-ray crys-
tallographic studies provide a useful guide to the inter-
pretation of data from these other sources (5).
On the basis of a previous analysis of the structures
of a variety of compounds that compete for binding to
the estrogen receptor, we have proposed that the phe-
nolic A ring of steroidal estrogens is primarily respon-
sible for initiating receptor binding and that the D ring
end ofthe steroid molecule is primarily responsible for
governing biological activity (6). The following obser-
vations support this model. The only common feature
of compounds that compete with estradiol for binding
to the estrogen receptor with relatively high affinity is
a phenolic ring. Simple compounds such as tetrahy-
a)
dronaphthol and p-sec-amyl phenol prevent or compete
for the binding of estradiol to its receptor (7). Cher-
nyaev et al. (8) have demonstrated that the removal of
the 3-hydroxyl substituent significantly decreases re-
ceptorbindingwhile retaining some portion ofbiological
activity. Removal ofthe 17-hydroxyl was shown to de-
crease binding to a lesser extent than 3-hydroxyl re-
moval but to almost totally abolish biological activity
(8).
Anaylsis of the crystallographic data and molecular
mechanics calculations for a series of estrogenic and
antiestrogenic analogs, derivatives, and metabolites of
diethylstilbestrol and triphenylethylene provide addi-
tional information concerning the structural basis for
receptor binding and hormonal action of estrogens.
Estradiol and Diethylstilbestrol
On the basis of an examination ofmodels ofestradiol
and the potent synthetic estrogen diethystilbestrol
(DES) (Fig. la and b), Keasling and Schueler (9) pro-
posed thatthe structuralrequirements forestrogenicity
were a specific distance (14.5 A) between two hydroxyl
groups separated by a flat hydrophobic region. Subse-
quent X-ray crystallographic studies haverevealed that
the distances between the terminal oxygen groups in
estradiol (10) and diethylstilbestrol (11) are 10.9 and
12.1 A (Fig. 2a and b), respectively, and that the mol-
ecules (particularly DES) are not as flat as their con-
ventional chemical drawings might suggest. The small
but significant difference between the oxygen-oxygen
distances in these structures cannot be overcome by
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FIGURE 1. Chemical diagrams, atomic numbering and ring identification for (a) estradiol, (b) diethylstilbestrol, DES, (c) indenestrol A, INDA,
(d) indenestrol B, INDB, (e) indanestrol, INDC, (f) Z-pseudo diethylstilbestrol (ZPD), (g) E-pseudo diethylstilbestrol (EPD), (h) trans- and
(i) cis-tamoxifen.
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a)
FIGURE 2. Comparison of the overall conformation of (a) estradiol,
and (b) DES, viewed parallel to the plane ofthe A-ringin estradiol
and one of the phenyl rings in DES.
molecular flexibility. The fairly rigid fused ring system
ofestradiol and the central double bond in DES prevent
the oxygen from getting more than 0.1 A closer to each
other. Ifa specific distance between two hydroxyl groups
is essential for estrogenic activity the 1.2 A disparity
between this distance in estradiol and DES could in-
dicate that a water molecule plays a significant role in
acting as a link between estradiol and the receptor (6).
The distance between 0(3) and a hydrogen-bonded ox-
ygen in estradiol hydrate is 12.1 A identical to the dis-
tance in DES (Fig. 3).
Although the oxygen-oxygen distance in DES is nearly
fixed, conformational variation in the overall shape of
the molecule is possible. Five distinct crystallographic
observations of DES have resulted from studies of an
anhydrous (12) and three solvated crystal forms (11).
The DES molecule observed in the anhydrous crystal
has crystallographically imposed inversion symmetry
FIGURE 3. Superposition drawing ofsolvated estradiol and DES, maximizing relative positioning ofhydrophilic groups and hydrophobic bulk.
03' is the hydroxyl group of an adjacent molecule in crystals of estradiol. Hydrogen bonds are indicated as broken bonds.
(C)
FIGURE 4. Stereo views of the crystallographically observed conformation of DES: (a) the conformation observed in anhydrous crystals, (b)
a comparison of the conformation observed in three different solvated forms of DES and (c) the comparison of the conformation in the
solvated (solid) and anhydrous (dashed) forms.
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FIGURE 5. Stereo diagrams comparing the crystallographically observed conformations (solid) of (a) anhydrous and (b) solvated DES with
the conformations predicted by molecular mechanics calculations to be local minima (dashed).
(S2) about the midpoint of the ethylene bond (Fig. 4a).
The molecules in the solvated crystal forms are signif-
icantly different from the anhydrous conformer, and
nearly identical to one another (Fig. 4b). The solvated
molecules have approximate C2 symmetry with the ro-
tation axis perpendicular to the plane of the ethylene
bond and both of the methyl groups on the same side
ofthe plane ofthe double bond. When the molecule from
the anhydrous crystal is compared with one ofthe mol-
ecules from the solvated crystals (Fig. 4c), half of the
molecule is seen to be nearly identical and the other
half differs by correlated variations of the 42 and 4+
torsion angles that results in a conversion from S2 sym-
metry to C2 symmetry. Neither ofthese conformations
is particularly flat with the dihedral angles between the
phenyl rings being O in the solvated molecule and 600
to 700 in the anhydrous form. The molecular mechanics
program MM2p* was used to refine the conformational
isomers of DES afforded by the X-ray determinations
of solvated anhydrous crystal forms. The calculations
are for the isolated molecules and no solvent present.
In Figure 5a and b the calculated molecules having
C2h and C2 symmetry are compared with the corre-
sponding crystallographically observed conformations
by least-squares fitting ofthe atoms of one ofthe rings.
This fit illustrates excellent overall agreement between
the X-ray results and the calculations.The relative ener-
gies calculated for the anhydrous and the solvated mol-
ecules are 3.1 kcal/mole and 3.4 kcal/mole, and the
calculated dipole moments are 0.0 and 2.2, respectively.
The dipole moment of the molecule may well have a
significant influence on complementarity of hormone-
receptor interaction. The calculated dipole for estradiol
in its solid state conformation is 2.3. The solid-state
observation andthe energycalculations ofthetwo forms
argues in favor of their being ofcomparable (near min-
imum) energy. Molecular environment will determine
which ofthe two forms predominates. It is unlikely that
the two conformations compete equally for the receptor
site or are equally effective at eliciting hormonal re-
sponse. The receptor may select one ofthe conformers.
Hospital et al. (15) have concluded on the basis of hy-
drogen-bonding patterns and overall conformational
features that it is the conformation observed in the sol-
vated crystals thatisresponsible forbothreceptorbind-
Table 1. Summary of reported binding affinities and uterotropic
activities of estradiol (E), DES, indenestrol A(INDA),
indenestrol B(INDB), and indanestrol (INDC).
Doubling dose,
Compound C50, nmole/L' ,lg/kgb
E 1.0 0.1 10
DES 1.0 ± 0.1 7
INDA 0.7 ± 0.1 107
INDB 0.7 ± 0.2 111
INDC 50 ± 5 1120
aNanomolar concentration of competitor required for 50% inhibi-
tion ofspecific binding of[3H] estradiol. Results are expressed as the
mean ± SE for a minimum of four determinations.
bValues are expressed as dose (,ug/kg) of compound required to
produce a 2-fold increase above the control of uterine weight/body
weight ratio in 21-day-old CD-1 mice treated for 3 days. Data taken
from Duax et al. (20).
ing and hormone action. The similar values ofthe dipole
moments of estradiol and the DES conformer seen in
the solvated crystals also supports the contention that
itisthis DES conformerthatitmost suitedtomimicking
estradiol in its binding to the estrogen receptor.
Indanestrol and Indenestrol
A series ofindanyl DES derivatives have been iden-
tified as in vivo metabolites of DES (16). These com-
pounds possess effective receptor binding affinity but
poor biological activity. Structures of the compounds
indenestrol A (INDA) [1-ethyl-2(4'-hydroxyphenyl)-3-
methyl-5-hydroxyindene] indenestrol B (INDB) [1-
methyl-2(4'-hydroxyphenyl)-3-ethyl-6-hydroxyindene],
and indanestrol (INDC) [1-ethyl-2-(4'-hydroxyphenyl)-
3-methyl-5-hydroxyindane], are illustrated in Figure 1
(c, d, and e). The binding affinities ofthese compounds
relative to those ofestradiol (E) and DES as determined
by competitive equilibrium receptor binding analysis
and in vivo bioassay are presented in Table 1 (17,18).
There are three crystallographically independent
molecules present in crystals of INDA (18). Although
the molecules have slightly different crystalline envi-
ronments and distinctly different hydrogen-bonding
geometries, their conformations are nearly identical.
The conformation of the three molecules of INDA are
compared in Figure 6a. The atoms ofthe I and -y rings
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(a)
(b)
(c)
FIGURE 6. Stereo diagrams comparing the crystallographically observed conformation of (a) three conformers of INDA, (b) two conformers
of INDB and (c) the single conformer of INDC. All structure determinations contain racemic pairs. Only one of the enantiomers in each
pair is depicted above.
are coplanar and the ox ring is twisted 270, 310 and 330
out of that plane in the three crystallographically in-
dependent molecules. The C(3) methyl substituent and
the terminal methyl ofthe ethyl substituent are on the
same side of the plane of the , ring.
There are two crystallographically independent mol-
ecules present in crystals of INDB (19). The relative
orientation of the planar rings are nearly identical to
that observed in INDA. The ,B and y rings are coplanar
and the a, rings are rotated 330 out of that plane. The
two molecules of INDB differ significantly in the ori-
entation of the C(11) methyl groups as illustrated in
Figure 6b. The C-methyl atom is trans to the C(2)-C(3)
bond in one molecule and oriented overthe 3 ring, gauche
to the C(2)-C(3) and C(3)-C(9) bond in the other.
The observed conformation of INDC is illustrated in
Figure 6c. The methyl, ethyl, and phenyl substituents
are all on the same side ofthe five-membered ring with
the phenyl in an axial position and the ethyl and methyl
substituents inequatorialpositions. Because oftheaxial
orientation of the phenyl substituent the molecule has
an L-shape uncommon for the DES analogs.
The principle source of potential flexibility in the
structures of INDA and INDB are rotations about the
C(2)-C(1') bonds and the orientation ofthe C(11) methyl
group. The X-ray crystal structure results indicate that
there is ahighly restricted global minimum energy con-
formation in which the a ring is rotated away from
coplanarity in order to strike a balance between unfa-
vorable 1-4 and 1-5 nonbonding interactions and the
energetic advantage of additional conjugation possible
in a coplanar arrangement. The 30 +20 rotation is in the
direction that avoids unfavorable contacts between the
acring and the methyl substituent in INDA or the ethyl
substituent on the INDB.
When the crystallographically observed conforma-
tions of INDA, INDB and INDC are subjected to po-
tential energy minimization calculations using the MM2p
program, the molecules undergo small changes at the
two principal points of flexibility; rotations about the
C(2)-C(1') and the C(M)-C(10) or C(3)-C(10) bonds. The
torsion angles involving these bonds in the calculated
conformations differby 2-17° fromthose observed crys-
tallographically. The conformational isomers of INDB
are calculated to have relative energies of2.1 kcal/mole
and 1.5 kcal/mole, in qualitative agreement with the
nearly equal energy of the conformers suggested by
their co-crystallization. The calculated and observed
structures of INDA are compared in Figure 7, illus-
tratingthe excellent agreementinoverallconformation.
When the conformation of the ,B ring in INDC was
altered placing the a ringin an equatorialconformation,
energy minimization suggested that this is ametastable
form of 4.1 kcal/mole higher energy than the crystal-
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lographically observed conformation. This calculation is
compatible with the lowerbindingaffinity and hormonal
activity of the INDC structure relative to INDA and
INDB, but probably underestimates the energy
difference.
Because INDA, INDB and INDC all containtwophe-
nolic rings capable ofmimicking the A ring ofestradiol
in its interaction with the receptor, each could conceiv-
ably bind in four different orientations. Because they
are all racemic mixtures and there are four orientations
possible for each enantiomer, there are eight ways that
each could bind. The presence ofthe double bond in the
five-membered ring ofINDA and INDB forces them to
have relatively flat, fully extended conformations in
which both phenolic rings are exposed permitting ready
access to either surface of either ring. For this reason
they are found to compete for the estrogen receptor
with affinities comparable to that of DES (17,18). The
reduction in binding of INDC is almost certainly due to
its bent ring L-shaped conformation. Although the phe-
nolic rings could be expected to have some affinity for
the binding site, the L-shape appears to interfere with
optimal receptor interaction.
Despite the fact that INDA and INDB compete suc-
cessfully with DES for binding to the estrogen receptor
they are found to have approximately 1/15 the utero-
tropic biological activity of DES. This significant re-
duction in activity could be due to the fact that (1) both
enantiomers are notequivalent inbiological activity and
(2) notallofthefourpossibleligand bindingorientations
(Fig. 8) in the receptor are capable of inducing the bi-
ological activity of the receptor complex. If the y ring
ofINDA or INDB were to mimic the A ring ofestradiol
(Fig. 8c and d) and bind to the receptor the hydroxyl
on the at ring would be so far displaced from the 0(17)
position that it would fail to fulfill the role of 0(17) in
promotinghormone action. Ifonly one ofthe eight bind-
ing modes possible for a racemic mixture of INDA (or
INDB) has the proper orientation of the second hy-
droxyl group it would account for the reduction in bi-
ological activity that is observed despite evidence that
INDA, INDB, and DES compete equally well in vitro
for the estrogen steroid hormone binding site on the
receptor.
Pseudo-DiethylstiIbestrol
A diethyestrilbestrol analog, called pseudo-DES, in
which the double bond is between C(7) and C(8) rather
than C(7) and C(7') can exist in Z and E configurations
(Fig lf and g). Biological testing revealed that while
C)I &*%0.^$ 4.7,
0_
FIGURE 7. A comparison between the observed (solid) and calcu-
lated (dashed) structures of INDB.
a)
b)
0
I d)
FIGURE 8. Illustration ofthe four principal orientations in which the a or y rings of INDA and INDB can mimic the A ring ofestradiol when
binding to the estrogen receptor. The example illustrated is INDA (dashed) and estradiol (solid).
116CONFORMATION, BINDING, AND ACTIVITY OF ESTROGENS
Table 2. Comparison ofthe torsion angles defining the crystallographically observed and energy minimized conformation of
ZPD, EPD, and 1-OH-ZPD.
Torsion angle rangea
EPD ZPD 1-OH-ZPD Range
Observed in X-ray crystal
structure determinations -)48.4 -62.8 -55.8 14.40
4)2 77.0 75.6 71.6 5.40
4)3 54.5 49.6 51.5 4.90
4)4 -58.4 -57.6 -57.7 0.8°
Calcd for structures refined
using the MM2p program 4) -45.3 -58.3 -59.1 13.8
4)2 79.6 77.3 74.0 5.6
4)3 56.7 64.5 64.4 7.8
44 -58.6 -62.5 -62.5 1.3
all~= C(2)-C(1)-C(7)-C(8),4)2 = C(1)-C(7)-C(7')-C(1'),4)3
= C(7)-C(7')-C(1')C(6'), 4)4
= C(7)-C(7')-C(8')-C(9');atomicnumberingasinFigure
lf and lg.
Table 3. Comparison between observed and calculated average
values for the four torsion angles defining the conformation of
ZPD, EPD, and 20-OH-ZPD.
A(calcAvg
Observed Calculated obSAvg)
(+i --55.6 14.4 -59.1 13.8 3.5
4)2 74.7 5.4 74.0 5.6 0.7
'03 51.9 4.9 64.4 7.8 12.3
N 4-57.9 0.8 -62.5 1.3 4.6
both isomers retained appreciable but different affinity
forthe estrogen receptor, the Z isomer (ZPD) has twice
the uterotropic activity of the E (EPD) isomer (21).
Since a significant conformational difference between
the two might account for the observed activity differ-
ence, the X-ray crystal structure analyses of the two
forms and the 1-OH derivative of ZPD were under-
taken. The results revealed striking similarities in the
observed conformation despite differences in compo-
sition, connectivity, hydrogen bondingand crystalpack-
ing. Four torsion angles fully define the overall
conformation ofthese molecules (Table 2). The range in
variation of three of these four torsion angles is 50 or
less. The only significant variation is in the C(2)-C(1)-
C(7)-C(8) torsion angle which differs by 14.40 between
EPD and ZPD. The difference is a direct consequence
of the sterochemical differences between the E and Z
configurations. All three structures are observed to have
a bent conformation in which the phenyl rings are ori-
ented at right angles to one another (Fig. 9). This con-
formation is completely unlike the conformations of
estradiol, DES and the indenestrol isomers, but bears
someresemblance toindanestrol, acompound withlittle
affinity for the receptor.
When the crystallographically observed conforma-
tions of EPD, ZPD and 1-OH-ZPD were subjected to
energy minimization the structures retained their over-
all conformation with minor changes in their individual
torsion angles (Tables 2 and 3).The standard deviation
in the three observed 44 angles is only 0.80, providing
0
FIGURE 9. Stereo view of the superposition of ZPD, EPD, and 1-
OH-ZPD, illustrating the similarity in their crystallographically
observed conformations.
persuasive evidence that the conformation of this part
ofthe molecule is highly inflexible, unperturbed by the
Z to E variation, the addition of a hydroxyl group and
the associated reorganization and crystal packing and
all intermolecular contacts.
The consistency of the crystallographic results sug-
gests that the bent form is the energy minimum con-
formation for ZPD, EPD and 1-OH ZPD. However,
previous studies indicate that this conformation is un-
likely to be compatible with any significant degree of
estrogenic biological activity. For this reason it became
important to determine whether an extended DES-like
conformation might constitute a metastable state ca-
pable of inducing estrogenic biological response. The
crystallographically observed structures of ZPD and
EPD were transformed to the DES-like extended con-
formation and subjected to energy minimization. As a
result of extremely close contacts between the hydro-
gens on C(9) and the ot ring in EPD (Fig. 10a), the
extended conformation is stereochemically untenable and
the molecule refined to a bent conformation resembling
inoverall shape the crystallographically observed struc-
ture. In contrast to this, the extended conformation of
the more active Z isomer does not incorporate intoler-
able nonbonding interactions and refinement indicates
that ametastable state exists which resembles the DES
conformation (Fig. 10b).
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a)
energy
minimization
Extended EPD Reverts to gauche form
6.0 kcal/mol
b)
energy
minimization
Extended ZPD Remains extended
3.7 Kcal/ mol
FIGURE 10. When theoretical DES-like extended conformers of(a) EPD and (b) ZPD were used as the starting point for energy minimization,
EPD reverted to a bent conformation but ZPD retained an extended conformation.
Tamoxifen
A number oftriphenylethylene derivatives exhibiting
antiestrogenic properties are in use in cancer chemo-
therapy. The trans or Z isomer of tamoxifen (Fig. lh)
is one ofthe most potent antiestrogens. In contrast, the
E isomer of tamoxifen (Fig. li) is reported to exhibit
only weak estrogenic properties. The therapeutic prop-
erties of trans tamoxifen are primarily a result of the
competition forbinding to estrogen receptorofitsmajor
metabolite, 4-monohydroxy tamoxifen, where the hy-
droxyl has added to the 4" position on the a' ring (Fig.
lh). Although the X-ray crystal structure of 4-mono-
hydroxy trans tamoxifen has not been reported, those
of the trans (22) and cis (3) isomers of the parent com-
pound provide a useful guide to the probable confor-
mation of the active metabolite.
The E isomer (cis) crystallized with two conforma-
tionally distinct molecules in the crystal lattice (3). The
two conformations (compared in Fig. 11) differ subtly
in relative ring orientation and significantly in the con-
formation ofthe alkylamino ethoxy side chain. The rel-
ative ring orientations in the two isomers are almost
identical as illustrated by the superposition of the 1B
rings in the two structures shown in Figure 12.
The overall conformation oftamoxifen analogs can be
defined by seven torsion angles, four relating the sub-
stituents on the ethylene group and three in the alkyl-
aminoethoxy side chain. When the crystallographically
observedconformations ofZ and E isomers oftamoxifen
are subjected to energy minimization, these torsion an-
gles change by 5 to 250. The most significant changes
occur in the torsion angles defining the orientation of
the phenyl rings relative to the ethylene group. The
observed and refined conformations of the cis isomer
are compared in Figure 13.
It is reasonable to suppose that relative to the estra-
diol A ring the phenol ring of monohydroxy tamoxifen
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FIGURE 11. Comparison ofthe two crystallographically observed conformers ofcis (E) tamoxifen illustrating the similarity in the substituted
ethylene group and variations in the alkylamine-ethoxy side chain orientation.
/
FIGURE 12. Comparison illustrating the similarity of the observed conformations of E and Z tamoxifen with I rings superimposed.
FIGURE 13. Comparison of observed and calculated conformations of cis tamoxifen, with P rings superimposed.
would bind to the receptors in one of the two ways
illustrated in Figure 14. In either orientation, the ab-
sence of oxygen substitution comparable to 0(17) on
estradiol may account for the inactivity/antagonism of
thecompound. Inadditiontothis, theamino-substituted
ring may present steric interference to a molecular event
(i.e. conformational change in the receptor or genomic
interaction) that is essential to hormone action. It may
be that when bound to the receptor in one of these
orientations trans tamoxifen conveys antiestrogenic ac-
tivity, while in the other form it is merely an impeded
weak agonist.
Summary
The X-ray crystallographic structural determinations
ofsynthetic estrogens and antiestrogens described here
provide reliable information on the global minimum en-
ergyconformationofthesemolecules oralocalminimum
energy conformation that is within one or two kiloca-
lories per mole of the global minimum. The similarity
inmultiple observations ofDES, ofINDAand ofINDB,
despite extensive variation in intermolecular interac-
tions indicates that these molecules have well defined
minimum energy conformations that exhibit minimal
distortion as a result of crystal packing interactions.
This conclusion is consistent with those previously drawn
on the basis of examination of the 17 side chain of 85
pregnane structures (5) and an accurate low tempera-
ture neutron diffraction study of20-methyl-5-pregnene-
3P,20-diol (23). In favorable cases, state-of-the-art mo-
lecular mechanics calculations provide quantitative
agreement with X-ray results and information on the
relative energy of other local minimum energy confor-
mations not observed crystallographically. While the
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(b)
FIGURE 14. Comparison of the crystallographically observed conformation and hydrogen bonding of estradiol with that of trans tamoxifen.
For purposes ofthe comparison, the A ring of estradiol is superimposed on the a' phenyl ring of tamoxifen that is hydroxylated in animal
metabolism. The two possible superpositions of these rings are illustrated in (a) and (b). Common structural features are dark, estradiol
structure is shaded, and trans tamoxifen is light.
MM2p program provides reliable information on bond
lengths, angles, and some torsional angles, it fails to
minimize correctly the torsional relationship for C(sp3)-
C(sp2) formal single bonds.
Because the conformation of DES observed in sol-
vated crystals has an overall conformation and dipole
moment more similar to estradiol it is the form more
likely to bind to the receptor and produce hormone ac-
tivity. EitherphenolringofDES cansuccessfully mimic
the estradiol A-ring in binding to the receptor. Inde-
nestrol A and indenestrol B have nearly identical fully
extended planar conformations. Either the a or y rings
of these compounds may mimic the A ring of estradiol
and compete for the estrogen receptor. Although there
are eight distinct ways in which molecules ofa racemic
mixture of INDA or INDB can bind to the receptor,
not allofthemmaybeabletoelicitahormonalresponse.
This may account for the reduced biological activity of
the compounds despite their successful competition for
receptor binding. The bent conformation ofindanestrol
together with the relative instability of an extended
conformer are consistent with the low receptor affinity
and lack of activity of this compound.
Theminimum energyconformations ofZPD and EPD
are bent in a fashion similar to that of INDC. These
molecules have good binding affinity even with the bent
shape, suggesting that the receptor does not require a
flat molecule. Therefore these conformations would ap-
pear to be compatible with receptor binding, but only
the Z isomerhas an energetically allowed extended con-
formation that accounts for its observed biological ac-
tivity relative to DES. The phenolic ring of the
monohydroxylated metabolites ofthe potent antiestro-
gen Z-tamoxifen almost certainly mimics the steroid A-
ring in binding to the estrogen receptor. When this ring
is superimposed upon the A-ring ofestradiol, it is clear
that the antiestrogenic character of Z-tamoxifen stems
from the absence of a hydroxyl group located in a po-
sition analogous to that ofthe 17,-OH in estradiol. The
additional phenyl ring may interfere with an activity
controlling macromolecular interaction that follows re-
ceptor binding.
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base associated with this investigation and several ofthe illustrations
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The MM2p program is derived from the programs MM2 and MMP1
that have been developed by Norman Allinger (13,14) and are avail-
able from the Quantum Chemical Program Exchange. The MM2p
program incorporates the Variable Electronegativity Self-consistent
Field portion of the MMP1 program into the MM2 program.
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